Ignite Creation Date:
2024-05-05 @ 11:48 AM
Last Modification Date:
2024-10-26 @ 9:13 AM
Study NCT ID:
NCT00137917
Status:
COMPLETED
Last Update Posted:
2016-09-16
First Post:
2005-08-26
Brief Title:
Immunogenicity Safety Study of a Meningococcal Serogroup B Vaccine Given in a 3 Dose Schedule to Healthy Adolescents Aged 12-18 Yrs
Sponsor:
GlaxoSmithKline
Organization:
GlaxoSmithKline
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Infections Meningococcal |
Keywords:
| Name | View |
|---|---|
| Prophylaxis meningococcal serogroup B disease | View |